GSK and Novartis complete deals to reshape both drugmakers
March 02, 2015 at 02:09 AM EST
LONDON, March 2 (Reuters) - GlaxoSmithKline and Novartis said on Monday they had completed a series of asset swaps worth more than $20 billion that will reshape both drugmakers.